Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and differentiation sustains healthy blood formation. In myelodysplastic syndrome (MDS), however, this ...
Dec 13, 2025
0
6
A new national study shows for the first time that people exposed to Agent Orange face a higher risk of developing myelodysplastic syndrome (MDS), tend to develop it earlier, and often have more aggressive disease that is ...
Dec 8, 2025
0
0
Myelodysplastic syndrome (MDS) is independently associated with incident cardiovascular disease (CVD), according to a study published online Nov. 10 in the Canadian Journal of Cardiology.
Nov 25, 2025
0
0
Blood cancers such as leukemia are caused by genetic changes in the blood-forming stem cells of the bone marrow. Scientists at the University Medical Center Mainz have now shown how chronic inflammation can alter the bone ...
Nov 18, 2025
0
6
Researchers from King's have identified a new way to treat certain blood cancers using existing drugs, by turning a once-dismissed part of our DNA into a therapeutic target.
Sep 11, 2025
0
1
Researchers at Karolinska Institutet have identified a vulnerability in certain blood cancer cells that makes it possible to eliminate the cancer cells with a drug, without harming healthy cells. The study is published in ...
Sep 2, 2025
0
28
Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to results published in Blood Neoplasia. The findings suggest that ...
Aug 6, 2025
0
0
The targeted drug olutasidenib is highly effective in certain patients with myelodysplastic syndrome (MDS), a condition considered incurable without transplantation, according to a new clinical study led by researchers at ...
Jul 28, 2025
0
0
The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk myelodysplastic syndrome (MDS), according to a study published online July 4 ...
Jul 24, 2025
0
0
Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), according to a study published online June 26 in the European Journal of Haematology.
Jul 23, 2025
0
0
